AM Rx Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 5.4/10
Best for: compounded semaglutide at $151/month
AM Rx falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
AM Rx is a telehealth platform operated by FitRX, LLC, which also operates Zealthy and FitRx. Compounded semaglutide starts at $151/mo on a quarterly plan, and brand-name GLP-1s, Ozempic, Wegovy, Zepbound, and Mounjaro, come with insurance coordination as low as $25/mo. Consultations can be video or async. HSA/FSA accepted.
Is AM Rx legit?
AM Rx is a real, operating US company, and the FDA has issued it 3 warning letters. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate AM Rx 5.4/10 overall.
Is there an AM Rx promo or coupon code?
AM Rx has no code to type in. The current offer: Limited Time: $96 off your first month / $96 off AM Rx Weight Loss Program (. It applies at checkout on its own. Coupon sites advertising an "AM Rx promo code" are not a source we can vouch for.
See how AM Rx compares on our rankings of the best semaglutide providers.
Vetted alternatives to AM Rx
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
AM Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Wegovy, Ozempic, Zepbound, Mounjaro
- Starting price
- $151/mo
- FDA status
- 3 FDA warning letters (details below)
How AM Rx scores
Six columns, each one computed from something AM Rx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.5/10$151/month is 18% below the $185 median for compounded semaglutide across the sellers we compare. That figure is a multi-month plan paid up front, not a month-to-month rate, so the comparison flatters it.
Effectiveness25%
9.0/10Dispenses semaglutide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
1.0/10The FDA has issued it 3 warning letters. No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on AM Rx
Last checked August 2026- Checked the listed price across 3 dose or plan tiers
- Checked FDA warning letters for AM Rx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with AM Rx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1AM Rx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask AM Rx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $151. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that AM Rx serves your state before you start.
- The FDA has issued AM Rx 3 warning letters. They are covered in the enforcement section below; read what they allege before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting AM Rx
- Phone
- (585) 699-1164
- AM Rx offers email support
Cancelling AM Rx
Taken from the terms AM Rx publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- 3-month prepay
- Refund policy
- Not published by the seller
GLP-1 medications AM Rx offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
As low as $25/mo with insurance coordination; a separate AM Rx membership is still required.
Medication only ($151/mo when purchased quarterly); the recurring AM Rx membership is billed on top.
Standard $135/mo membership, $39 first month ($96 off promo); renews monthly. Medication is billed separately. drug omitted intentionally.
Check the price yourself before you pay
Every figure here was read off AM Rx's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $151 a month, 18% below the $185 median for compounded semaglutide across the sellers we compare
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued AM Rx 3 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What AM Rx charges
AM Rx lists $151/month. That sits at the affordable end of what we see.
- Brand-name semaglutide with insurance: $25/month
- Compounded semaglutide: $151/month
- Required AM Rx membership (subscription, separate from medication): $39 first month, then $135/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so AM Rx's $151 is genuinely below the middle, not just advertised that way.
SkinnyRx dispenses semaglutide and tirzepatide from $149.25/month, which makes it the fair comparison to run before you commit here.
What AM Rx dispenses
AM Rx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade.
Safety and disclosure
Before you start an intake, ask AM Rx which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. The FDA has issued AM Rx 3 warning letters, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. The pharmacy question matters most here because the medication is compounded. If AM Rx will not name the pharmacy, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want to try routing the cost through your insurance
Our read
AM Rx competes on price, and at $151/month it competes well. The FDA warning letter is what to weigh against that, not a footnote to it. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
AM Rx falls below our bar on oversight: the FDA has issued it a warning letter. Read the breakdown below before you give it money.
Before you pay AM Rx
Starting at $151 a month. Check today's price, then start the intake.
Where AM Rx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare AM Rx head to head
The sellers closest to AM Rx on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
AM Rx has an FDA warning letter on record, dated June 8, 2026
This letter concerns false & misleading claims/misbranded (telehealth). A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this AM Rx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See AM Rx's current pricing
Plans start at $151 a month. Whether you qualify is a clinician's decision, made after your intake.